This article explores the causes of high-throughput screening assay failures, how these failures manifest in screening ...

As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How ...

In drug discovery, in vitro models have a pivotal role by providing defined experimental systems for the investigation of cellular responses to pharmacological agents. Human cell lines have ...

An integrated suite of bioassays provides a coherent workflow to track antibody Fc effector activity across every stage of mAb drug development Potency assays that fail during tech transfer or ...

This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Life sciences is among the most ...

From axolotls to zebrafish, stem cells possess remarkable regenerative abilities, enabling them to restore lost limbs and repair damaged organs. These extraordinary capabilities, however, are not ...

Caitlin Mills (left) is a lecturer in systems biology at Harvard Medical School (HMS; MA, USA) and Director of Preclinical Pharmacology in the Laboratory of Systems Pharmacology (LSP) at HMS. Caitlin ...

Traditionally, developing a new drug takes many years and requires a massive financial investment, often involving significant risk and a high likelihood of failure. AI models trained on extensive ...

Join Dr. Mikael Kubista, a pioneer of developing and standardizing real-time quantitative PCR (qPCR) and digital PCR (dPCR) assays for research and diagnostics. As a member of the American Association ...

You don't want to miss this! To permanently access this eBook for free, fill out the short form below. Developing robust, reproducible antibody pair-based immunoassays is critical for guiding drug ...